Appearance of Plasma Amino Acids Following Consumption of an Oral Nutrition Supplement

Société des Produits Nestlé (SPN)0 sites12 target enrollmentFebruary 2016

Overview

To assess the effect of consumption of an oral nutrition supplement on Arginine, a blood marker of nutritional intake

Registry

clinicaltrials.gov

Start Date

February 2016

End Date

May 2016

Last Updated

3 years ago

Study Type

Interventional

Study Design

Crossover

Sex

All

Sponsor

Société des Produits Nestlé (SPN)

Responsible Party

Sponsor

•Healthy subject (absence of metabolic disorder, heart disease, endocrine disease, cancer)
•Discontinued use of omega 3 fatty acid supplements - 10 days prior to testing
•Willing to provide signed informed consent

•Patients with potential for non-compliance
•Patients with allergy to ingredients in test products (i.e. milk protein, fish oil)
•Subject who in the Investigator's assessment cannot be expected to comply with study protocol
•Currently participating in another conflicting clinical trial.

Change in plasma arginine levels in µmol/L

Time Frame: Pre-consumption, 30, 60, 120, 180, 240 minutes

Change in plasma phospholipid Eicosapentaenoic acid (EPA) in µg/ml(Pre-consumption, 30, 60, 120, 180, 240 minutes)
Change in plasma-free phospholipid Eicosapentaenoic acid (EPA) in µg/ml(Pre-consumption, 30, 60, 120, 180, 240 minutes)